Author Description
Jaki Walsh is managing director, Derivati Consulting, a specialist consulting firm offering cross asset class expertise in the derivatives market; specifically focusing on the evolving market structure and the challenges relating to the implementation of EMIR / Dodd Frank Regulations.
With over 15 years of global experience in derivatives and project management across investment banking, asset management and central clearing, she has the unique benefit of having sell-side, buy-side and service provider experience in the Derivatives market. Jaki can be relied upon to deliver what is promised, will manage expectations and does not believe in staying within a ‘comfort zone’, rather “in getting my hands dirty to get the job done”.
Prior to founding Derivativ Consulting, Jaki was head of EMEA OTC Product at CME Group where she worked closely with buy and sell-side clients to support the successful launch of dealer-to-customer OTC clearing services. Jaki also held various roles at F&C Investments including group derivatives operational officer where she was responsible for the firms' group derivatives operational oversight, control and development and acted as the prime derivatives representative between both external and internal derivatives stakeholders including legal, compliance, derivatives counterparts, clears and outsourced vendors.
Q&A: Asset Segregation for Cleared OTC Derivatives
A Q&A to address questions on asset segregation models to support cleared OTC derivatives from webinar attendees